4.6 Article

Sex-Specific B Cell and Anti-Myelin Autoantibody Response After Peripheral Nerve Injury

Journal

FRONTIERS IN CELLULAR NEUROSCIENCE
Volume 16, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fncel.2022.835800

Keywords

autoantibody; neuropathic pain; sex; sexual dimorphism; myelin; autoantigen

Categories

Funding

  1. NIH [R01 DE022757]
  2. NIH Office of Research on Women's Health (ORWH) Administrative Supplement for Research on Sex/Gender Differences
  3. U.S. Department of Veterans Affairs [5I01BX000638]
  4. UCSD Academic Senate [RS283B]

Ask authors/readers for more resources

Immunotherapy shows potential as a non-addictive treatment for refractory chronic pain. This study investigates the role of B cells in sex-specific responses to peripheral nerve trauma and suggests that targeting B cells with intravenous Rituximab therapy may reduce mechanical allodynia in females. The findings highlight the importance of understanding the biological basis of sex-specific responses to nerve injuries for personalized regenerative and analgesic therapies.
Immunotherapy holds promise as a non-addictive treatment of refractory chronic pain states. Increasingly, sex is recognized to impact immune regulation of pain states, including mechanical allodynia (pain from non-painful stimulation) that follows peripheral nerve trauma. This study aims to assess the role of B cells in sex-specific responses to peripheral nerve trauma. Using a rat model of sciatic nerve chronic constriction injury (CCI), we analyzed sex differences in (i) the release of the immunodominant neural epitopes of myelin basic protein (MBP); (ii) the levels of serum immunoglobulin M (IgM)/immunoglobulin G (IgG) autoantibodies against the MBP epitopes; (iii) endoneurial B cell/CD20 levels; and (iv) mechanical sensitivity behavior after B cell/CD20 targeting with intravenous (IV) Rituximab (RTX) and control, IV immunoglobulin (IVIG), therapy. The persistent MBP epitope release in CCI nerves of both sexes was accompanied by the serum anti-MBP IgM autoantibody in female CCI rats alone. IV RTX therapy during CD20-reactive cell infiltration of nerves of both sexes reduced mechanical allodynia in females but not in males. IVIG and vehicle treatments had no effect in either sex. These findings provide strong evidence for sexual dimorphism in B-cell function after peripheral nervous system (PNS) trauma and autoimmune pathogenesis of neuropathic pain, potentially amenable to immunotherapeutic intervention, particularly in females. A myelin-targeted serum autoantibody may serve as a biomarker of such painful states. This insight into the biological basis of sex-specific response to neuraxial injury will help personalize regenerative and analgesic therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available